effici
synthesi
spirocycl
triazolooxazin
nucleosid
describ
achiev
convers
bdpsicofuranos
correspond
azidoderiv
follow
alkyl
primari
alcohol
rang
propargyl
bromid
obtain
sonogashira
chemistri
product
reaction
underw
addit
smoothli
gener
protect
spirocycl
adduct
easili
deprotect
give
correspond
ribos
nucleosid
librari
compound
obtain
investig
antivir
activ
use
mhv
mous
hepat
viru
model
wherein
deriv
f
show
promis
activ
toler
abstract
effici
synthesi
spirocycl
triazolooxazin
nucleosid
describ
achiev
convers
bdpsicofuranos
correspond
azidoderiv
follow
alkyl
primari
alcohol
rang
propargyl
bromid
obtain
sonogashira
chemistri
product
reaction
underw
addit
smoothli
gener
protect
spirocycl
adduct
easili
deprotect
give
correspond
ribos
nucleosid
librari
compound
obtain
investig
antivir
activ
use
mhv
mous
hepat
viru
model
wherein
deriv
f
show
promis
activ
toler
design
synthesi
nucleosid
analogu
subject
great
interest
discoveri
novel
anticanc
antivir
agent
owe
fact
involv
disrupt
nucleic
acid
biosynthesi
thu
inhibit
cellular
divis
viral
replic
addit
utilis
variou
genesilenc
techniqu
constitu
antisens
oligonucleotid
small
interf
rna
sirna
micrornatarget
oligonucleotid
antimirna
particular
conform
restrict
nucleosid
lock
nucleic
acid
lna
wherebi
sugar
moieti
nucleosid
lock
bioactiv
north
south
conform
repres
interest
class
nucleosid
inhibitor
show
dramat
improv
enzymat
recognit
well
enhanc
base
stack
backbon
preorganis
system
lock
virtu
bridg
group
furanos
unit
alon
also
exampl
wherebi
nucleobas
directli
involv
conform
restrict
nucleosid
socal
cyclonucleosid
respect
interest
synthesi
use
anomer
spironucleosid
wherebi
anomer
carbon
belong
sugar
moieti
nucleobas
figur
fix
nucleobas
specif
orient
around
nglycosid
bond
impos
alter
flexibl
sugar
moieti
spirofunctionalis
nucleosid
gain
consider
interest
discoveri
hydantocidin
natur
spironucleosid
potent
herbicid
plant
growth
regulatori
activ
howev
best
knowledg
synthet
work
field
limit
major
anomer
spirocycl
hydantoin
diketopiperazin
analogu
simpl
pseudonucleosid
anchor
purin
pyrimidin
base
part
ongo
programm
within
laboratori
synthesi
nonnatur
nucleic
acid
aim
prepar
librari
spirofuctionalis
nucleosid
contain
triazolyl
moieti
use
straightforward
highli
stereoselect
rout
felt
class
spironucleosid
would
make
interest
altern
triazolyl
class
nucleosid
biolog
activ
well
known
owe
resembl
ribavirin
therefor
evalu
result
triazolospironucleosid
antihmv
mous
hepat
viru
activ
vitro
depict
retrosynthet
path
scheme
versatil
synthet
strategi
toward
novel
anomer
spironucleosid
lie
strateg
instal
azid
alkyn
moieti
dpsicofuranos
deriv
follow
intramolecular
huisgen
cycloaddit
gener
spirocycl
triazolooxazin
ring
figur
represent
spironucleosid
share
carbon
anomer
posit
spironucleosid
hydantocidin
triazolyl
antivir
ribavirin
first
part
synthesi
shown
scheme
follow
gener
procedur
describ
fuent
cowork
involv
isomeris
easili
prepar
multigram
scale
use
straightforward
threestep
procedur
bdfructopyranos
furanos
form
use
amberlyst
acid
resin
aceton
remain
alcohol
convert
benzoat
ester
b
satisfactori
overal
yield
benzoat
ester
treat
azidotrimethylsilan
presenc
trimethylsilyl
triflat
acetonitril
stringent
anhydr
condit
min
provid
ether
sole
anom
silyl
group
remov
smoothli
mixtur
aceton
acet
acid
methanol
give
alcohol
yield
alkyl
alcohol
rang
propargyl
bromid
undertaken
use
bemp
base
give
crude
propargyl
ether
intermedi
partner
oalkyl
prepar
commerci
avail
aryl
iodid
propargyl
alcohol
use
twostep
process
involv
sonogashira
coupl
follow
convers
result
alcohol
correspond
bromid
appel
condit
see
support
inform
crude
propargyl
ether
intermedi
underw
effici
intramolecular
cycloaddit
upon
heat
toluen
h
give
novel
protect
anomer
spironucleosid
librari
tabl
final
deacyl
spiroderiv
use
n
solut
ammonia
methanol
follow
hydrolysi
isopropyliden
group
acid
resin
dowex
gave
straightforward
access
anomer
spironucleosid
good
yield
scheme
proof
final
structur
gain
understand
conform
system
xray
crystal
structur
g
obtain
thin
mm
singl
crystal
figur
structur
space
group
two
independ
molecul
asymmetr
unit
disord
benzen
ring
occupi
two
distinct
conform
b
differ
rotat
aryl
scheme
retrosynthet
access
spirotriazolooxazin
scheme
synthesi
azidoribos
system
encouragingli
consid
lock
natur
nucleosid
system
crystal
structur
overlaid
triazolyl
drug
ribavirin
show
remark
similar
conform
particularli
respect
ribos
ring
system
figur
prompt
us
evalu
antivir
activ
nucleosid
analogu
studi
describ
coronavirus
largest
complex
rna
virus
known
encod
unusu
wide
array
protein
interact
modifi
viral
rna
exampl
includ
sever
acut
respiratori
syndrom
sar
middl
eastern
respiratori
syndrom
mer
amongst
lethal
virus
current
known
coronavirus
predict
sensit
rnalik
drug
nucleosid
ribavirin
anticoronavir
activ
therefor
chose
model
coronaviru
mhv
prove
wwwchemeurjorg
ground
novel
nucleosid
analogu
describ
studi
antivir
activ
order
test
antivir
effect
mhv
grown
cell
pretreat
experiment
compound
concentr
mm
amount
mhv
releas
infect
cell
usual
peak
h
infect
two
treatment
b
f
reduc
amount
mhv
releas
tenfold
figur
mhv
infect
cell
normal
result
format
larg
multinucl
syncytia
follow
detach
cell
cultur
flask
effect
experiment
compound
previou
assay
screen
abil
protect
cell
mhvinduc
cytopatholog
cell
pretreat
f
h
infect
surviv
cell
photograph
h
infect
treatment
f
result
dosedepend
reduct
syncytium
format
detach
figur
b
data
conclud
f
exert
protect
effect
treat
cell
concentr
mm
also
demonstr
appar
antivir
activ
f
simpli
artefact
cytotox
detail
doserespons
experi
perform
four
experiment
compound
order
better
gaug
antivir
potenti
pretreat
mm
f
produc
strongest
antivir
effect
result
approxim
one
millionfold
reduct
mhv
growth
figur
c
togeth
result
demonstr
f
antivir
activ
model
coronaviru
mhv
mous
lung
fibroblast
line
support
hightitr
mhv
growth
therefor
chosen
toxic
antivir
test
effect
treatment
cell
viabil
assess
mtt
assay
cell
viabil
assess
one
day
three
day
compound
studi
promis
test
assay
compound
cytotox
b
f
k
includ
control
better
toler
figur
concentr
produc
reduct
cell
viabil
assay
greater
mm
experiment
compound
test
tabl
demonstr
compound
rel
nontox
experi
perform
order
learn
mechan
f
antivir
activ
evolv
drug
resist
mhv
serial
passag
eight
time
cell
pretreat
mm
f
concentr
reproduc
reduc
viral
growth
previou
work
antivir
compound
suggest
condit
appropri
select
drugresist
coronaviru
within
five
passag
howev
mhv
grown
presenc
f
consist
produc
viru
produc
untreat
control
cell
develop
resist
data
shown
result
suggest
mechan
action
f
unclear
effect
f
cell
rule
potenti
explan
antivir
effect
conclus
novel
triazolospirocylc
nucleosid
array
assembl
effici
intramolecular
cycloaddit
methodolog
allow
identif
agent
show
promis
antivir
activ
toward
mhvthe
promis
deriv
f
work
underway
establish
mechan
action
inhibitor
gie
xray
data
collect
structur
determin
g
keyword
alkyn
antivir
agent
cycloaddit
nucleosid
spiro
compound
